Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

6.46

+0.11 (1.73%)

Jul 10, 2026, 4:10 PM GMT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
ACCRUFeR®/FeRACCRU®	49.70M	32.18M	13.09M	5.50M	2.06M
ACCRUFeR®/FeRACCRU® Growth	54.45%	145.93%	137.95%	167.35%	-85.50%
Total	49.70M	32.18M	13.09M	5.50M	2.06M
Total Growth	54.45%	145.93%	137.95%	167.35%	-85.50%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
The Netherlands	2.76M	2.14M	1.50M	1.78M	1.23M
The Netherlands Growth	28.66%	43.28%	-15.77%	44.37%	-
Canada	831.00K	320.00K	-	185.00K	-
Canada Growth	159.69%	-	-	-	-
South Korea	-	122.00K	20.00K	6.00K	744.73K
South Korea Growth	-	510.00%	233.33%	-99.19%	-
Japan	338.00K	322.00K	-	-	-
Japan Growth	4.97%	-	-	-	-
United States	45.78M	29.27M	11.57M	3.53M	82.60K
United States Growth	56.37%	153.02%	228.13%	4168.87%	-
Total	49.70M	32.18M	13.09M	5.49M	2.06M
Total Growth	54.45%	145.93%	138.26%	167.01%	-85.50%